C. Bremard-Oury

407 total citations
12 papers, 245 citations indexed

About

C. Bremard-Oury is a scholar working on Immunology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C. Bremard-Oury has authored 12 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C. Bremard-Oury's work include Immunodeficiency and Autoimmune Disorders (8 papers), Blood groups and transfusion (5 papers) and Pediatric health and respiratory diseases (2 papers). C. Bremard-Oury is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (8 papers), Blood groups and transfusion (5 papers) and Pediatric health and respiratory diseases (2 papers). C. Bremard-Oury collaborates with scholars based in France and Sweden. C. Bremard-Oury's co-authors include C Griscelli, Guy Leverger, Nadine Cerf–Bensussan, G Schaison, Alain Fischer, Anne Durandy, Françoise Le Deist, Stéphane Blanche, Pièrre Aucouturier and J L Preud'homme and has published in prestigious journals such as The Lancet, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

C. Bremard-Oury

12 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bremard-Oury France 8 149 135 98 36 29 12 245
M. V. Ragni United States 9 163 1.1× 80 0.6× 80 0.8× 26 0.7× 14 0.5× 13 368
Shusaku Fukaya Japan 5 203 1.4× 146 1.1× 116 1.2× 10 0.3× 44 1.5× 16 290
J Goertz Netherlands 10 55 0.4× 175 1.3× 23 0.2× 36 1.0× 18 0.6× 13 330
Sen L Argentina 9 80 0.5× 126 0.9× 83 0.8× 14 0.4× 9 0.3× 32 333
Fenying Zhao China 7 178 1.2× 135 1.0× 99 1.0× 45 1.3× 9 0.3× 27 284
M Michel Austria 4 229 1.5× 144 1.1× 31 0.3× 25 0.7× 9 0.3× 6 347
B. Krackhardt Germany 7 441 3.0× 27 0.2× 29 0.3× 11 0.3× 30 1.0× 10 581
Hiromichi Take Japan 11 43 0.3× 83 0.6× 60 0.6× 56 1.6× 15 0.5× 31 299
Friederike S. Schuster Germany 8 179 1.2× 135 1.0× 110 1.1× 25 0.7× 12 0.4× 10 256
Stéphane Blanche France 4 225 1.5× 166 1.2× 144 1.5× 12 0.3× 5 0.2× 5 281

Countries citing papers authored by C. Bremard-Oury

Since Specialization
Citations

This map shows the geographic impact of C. Bremard-Oury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bremard-Oury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bremard-Oury more than expected).

Fields of papers citing papers by C. Bremard-Oury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bremard-Oury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bremard-Oury. The network helps show where C. Bremard-Oury may publish in the future.

Co-authorship network of co-authors of C. Bremard-Oury

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bremard-Oury. A scholar is included among the top collaborators of C. Bremard-Oury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bremard-Oury. C. Bremard-Oury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Bremard-Oury, C., Dominique Brault, M Voyer, et al.. (1991). Intravenous Immunoglobulin Therapy for Prevention of Infection in High-Risk Premature Infants: Report of a Multicenter, Double-Blind Study. PEDIATRICS. 88(3). 437–443. 37 indexed citations
3.
Preud'homme, J L, Pièrre Aucouturier, C. Bremard-Oury, & C Griscelli. (1990). [IgG subclass deficiencies].. PubMed. 47(3). 213–9. 5 indexed citations
4.
Bremard-Oury, C.. (1989). [Deficiencies in humoral immunity].. PubMed. 36(6). 357–64. 4 indexed citations
5.
Rjh, Smith, C. Bremard-Oury, F Le Deist, et al.. (1988). The antibody spectrum in individuals with defect expression of HLA class II and the LFA-1 glycoprotein family genes.. PubMed. 74(3). 449–53. 9 indexed citations
6.
Bremard-Oury, C., et al.. (1987). [Prevalence of anti-HIV antibodies in immunoglobulins recipients].. PubMed. 16(40). 2013–8. 1 indexed citations
7.
Aucouturier, Pièrre, C. Bremard-Oury, C Griscelli, Michel Berthier, & J L Preud'homme. (1987). Serum IgG subclass deficiency in ataxia-telangiectasia.. PubMed. 68(2). 392–6. 22 indexed citations
8.
Fischer, Alain, Nadine Cerf–Bensussan, Stéphane Blanche, et al.. (1986). Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. The Journal of Pediatrics. 108(2). 267–270. 116 indexed citations
9.
Aucouturier, Pièrre, C. Bremard-Oury, Jean‐Pierre Clauvel, et al.. (1986). Serum IgG subclass levels in primary and acquired immunodeficiency.. PubMed. 20. 62–74. 7 indexed citations
10.
Bremard-Oury, C., Pièrre Aucouturier, Marianne Debré, Preud'homme Jl, & C Griscelli. (1986). Immunoglobulin G subclasses in patients with immunodeficiencies.. PubMed. 20. 75–9. 7 indexed citations
11.
Bremard-Oury, C.. (1986). SCREENING FOR ANTIBODIES TO LAV/HTLV-III IN RECIPIENTS OF IMMUNOGLOBULIN PREPARATIONS. The Lancet. 327(8489). 1090–1092. 18 indexed citations
12.
Bremard-Oury, C., et al.. (1984). [Prognosis of the systemic forms of juvenile chronic arthritis. Apropos of 100 cases].. PubMed. 41(2). 91–7. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026